Skip to content

LUPUS NEXUS LANDMARK STUDY: A PROSPECTIVE REGISTRY AND BIOREPOSITORY

The Lupus Research Alliance is launching the Lupus Landmark Study, a groundbreaking health research study that will improve personalized treatments for people living with lupus. This will be the largest study of its kind in lupus research, and will include 3,500 adults diagnosed with lupus.

The study aims to transform lupus research and drug development through the creation of a research platform. The platform will be a source of important clinical data, patient reported data, and biological samples that will catalyze global collaboration, innovation, and precision medicine approaches in lupus.

null

Conditions de participation

  • Sexe:

    Male, Female, Intersex

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:
Participants must be:

Able to understand and comply with study procedures and voluntarily sign a written informed consent document

Age18 years or older at the time of enrolment

Have a diagnosis of Systemic Lupus Erythematosis




Exclusion Criteria:
Those who are currently pregnant.
Those whose age is less than 18 years.

Lieu de l'étude

University of Calgary
University of Calgary
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Étude parrainée par
University of Calgary
Participants recherchés
Plus d'informations
ID de l'étude: REB23-1555